{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:01:30Z","timestamp":1784584890757,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.critrevonc.2008.09.008","type":"journal-article","created":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T22:06:25Z","timestamp":1225836385000},"page":"259-270","source":"Crossref","is-referenced-by-count":144,"title":["Cholangiocarcinoma"],"prefix":"10.1016","volume":"69","author":[{"given":"Stefania","family":"Mosconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano D.","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Labianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Zampino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2008.09.008_bib1","volume":"vol. VIII","author":"Parkin","year":"2002"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib2","volume":"vol. IX","author":"Curado","year":"2007"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/gut.48.6.816","article-title":"Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968\u20131998","volume":"48","author":"Taylor-Robinson","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","article-title":"Changing international trends in mortality rates for liver, biliary and pancreatic tumours","volume":"37","author":"Khan","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","article-title":"Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?","volume":"40","author":"Shaib","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma","volume":"366","author":"Khan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2005.03.040","article-title":"Cholangiocarcinoma","volume":"128","author":"Lazaridis","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2006.09.011","article-title":"Molecular pathology of biliary tract cancers","volume":"250","author":"Fava","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/jhep.2003.50200","article-title":"Cholangiocarcinoma: current concepts and insights","volume":"37","author":"Gores","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00000658-199411000-00007","article-title":"Choledochal cyst disease. A changing pattern of presentation","volume":"220","author":"Lipsett","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF00294744","article-title":"Hepatolithiasis associated with cholangiocarcinoma","volume":"19","author":"Kubo","year":"1995","journal-title":"World J Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2249.1991.tb08151.x","article-title":"Immune responsiveness and parasite-specific antibody levels in human hepatobiliary disease associated with Opisthorchis viverrini infection","volume":"84","author":"Haswell-Elkins","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1046\/j.1440-1746.2002.02781.x","article-title":"Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology","volume":"17","author":"Okuda","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case\u2013control study","volume":"27","author":"Bergquist","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MEG.0b013e328224b935","article-title":"Risk factors for cholangiocarcinoma","volume":"19","author":"Ben-Menachem","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hep.20537","article-title":"Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy","volume":"41","author":"Sirica","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib20","first-page":"604","article-title":"Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma","volume":"49","author":"Isa","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.humpath.2003.10.012","article-title":"Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays","volume":"35","author":"Swierczynski","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/MOG.0b013e3280495451","article-title":"Cholangiocarcinoma: emerging approaches to a challenging cancer","volume":"23","author":"Patel","year":"2007","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archsurg.1983.01390100021006","article-title":"Carcinoma of the bifurcation of the hepatic ducts","volume":"118","author":"Tsuzuki","year":"1983","journal-title":"Arch Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.1711390210","article-title":"Pathological aspects of cholangiocarcinoma","volume":"139","author":"Weinbren","year":"1983","journal-title":"J Pathol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib26","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/cncr.10934","article-title":"Hepatic intraductal oncocytic papillary carcinoma","volume":"95","author":"Martin","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.amjsurg.2003.12.051","article-title":"Influence of age on surgical treatment of peripheral cholangiocarcinoma","volume":"187","author":"Yeh","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib28","series-title":"TNM classification of malignant tumours","author":"UICC (International Union Against Cancer)","year":"2002"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mge.2002.125105","article-title":"Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"56","author":"Siqueira","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3748\/wjg.v10.i3.427","article-title":"Utility of serum CA19\u20139 in diagnosis of cholangiocarcinoma: in comparison with CEA","volume":"10","author":"Qin","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib31","first-page":"167","article-title":"Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician\u2019s perspective","volume":"20","author":"Sharma","year":"1999","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib32","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2214\/ajr.168.4.9124155","article-title":"Cholangiocarcinoma at the hepatic hilus: sonographic findings","volume":"168","author":"Hann","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/00004728-199909000-00004","article-title":"Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI","volume":"23","author":"Zhang","year":"1999","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1572-0241.2000.01763.x","article-title":"Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings","volume":"95","author":"Yeh","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1634\/theoncologist.11-8-913","article-title":"What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma?","volume":"11","author":"Slattery","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gassur.2003.10.003","article-title":"Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma","volume":"8","author":"Anderson","year":"2004","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s005340050163","article-title":"Resection of hilar cholangiocarcinoma\u2014a European and United States experience","volume":"7","author":"Saldinger","year":"2000","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2004-828895","article-title":"Surgical management of cholangiocarcinoma","volume":"24","author":"Jarnagin","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib39","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/JCO.1997.15.3.947","article-title":"Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors","volume":"15","author":"Klempnauer","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00000658-199604000-00007","article-title":"Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma","volume":"223","author":"Su","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00000658-199809000-00011","article-title":"Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system","volume":"228","author":"Burke","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF01658686","article-title":"Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus","volume":"14","author":"Nimura","year":"1990","journal-title":"World J Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1067\/msy.2002.127555","article-title":"Improved survival in resected biliary malignancies","volume":"132","author":"Nakeeb","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0360-3016(99)00472-1","article-title":"Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma","volume":"46","author":"Todoroki","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib45","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0360-3016(02)02952-8","article-title":"Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer","volume":"54","author":"Kim","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000658-199506000-00017","article-title":"Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival","volume":"221","author":"Pitt","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib47","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9610(97)00203-1","article-title":"Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma","volume":"174","author":"McMasters","year":"1997","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib49","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2004-828894","article-title":"Photodynamic therapy for cholangiocarcinoma","volume":"24","author":"Berr","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib51","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.gastro.2003.07.015","article-title":"Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study","volume":"125","author":"Ortner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib52","article-title":"Treatment of cholangiocarcinoma II","author":"Chari","year":"2003","journal-title":"UpDate"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib53","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0360-3016(94)90115-5","article-title":"The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer","volume":"28","author":"Alden","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/1097-0142(19910715)68:2<289::AID-CNCR2820680213>3.0.CO;2-2","article-title":"Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases","volume":"68","author":"Flickinger","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib55","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0360-3016(02)02845-6","article-title":"Limitations of conventional doses of chemoradiation for unresectable biliary cancer","volume":"53","author":"Crane","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00001813-199806000-00004","article-title":"Weekly 24h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas","volume":"9","author":"Chen","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib57","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1200\/JCO.1996.14.8.2311","article-title":"Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer","volume":"14","author":"Patt","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib58","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/0959-8049(95)00323-B","article-title":"Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours","volume":"31A","author":"Ellis","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib59","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/cncr.20368","article-title":"Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma","volume":"101","author":"Patt","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib60","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/annonc\/mdg281","article-title":"Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer","volume":"14","author":"Kim","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cncr.21621","article-title":"Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma","volume":"106","author":"Park","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib62","first-page":"783","article-title":"Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas","volume":"48","author":"Kubicka","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib63","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1200\/JCO.2001.19.20.4089","article-title":"Treatment of inoperable and\/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study","volume":"19","author":"Gebbia","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cncr.20753","article-title":"Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial","volume":"103","author":"Alberts","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib65","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.2005.51.008","article-title":"Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial","volume":"23","author":"Knox","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2217\/14796694.2.4.509","article-title":"Chemotherapy for advanced cholangiocarcinoma: what is standard treatment?","volume":"2","author":"Mazhar","year":"2006","journal-title":"Future Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib67","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","article-title":"Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR Study","volume":"15","author":"Andr\u00e9","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib68","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000160701.38945.82","article-title":"Surgical management of hilar cholangiocarcinoma","volume":"241","author":"Hemming","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib69","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archsurg.1993.01420200045008","article-title":"Outcomes after curative resections of cholangiocarcinoma","volume":"128","author":"Nagorney","year":"1993","journal-title":"Arch Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib70","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/bjs.1800831217","article-title":"Outcome of treatment for distal bile duct cancer","volume":"83","author":"Fong","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib71","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1072-7515(97)00088-4","article-title":"Hepatic resection and transplantation for peripheral cholangiocarcinoma","volume":"185","author":"Casavilla","year":"1997","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib72","first-page":"614","article-title":"Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma","volume":"43","author":"Jan","year":"1996","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib73","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3748\/wjg.v11.i12.1779","article-title":"Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital","volume":"11","author":"Jan","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib74","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients","volume":"69","author":"Meyer","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib75","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","article-title":"Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature","volume":"7","author":"Shimoda","year":"2001","journal-title":"Liver Transplant"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib76","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib77","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/lt.21248","article-title":"The perspective of liver transplantation for cholangiocarcinoma","volume":"13","author":"Jonas","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib78","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archsurg.134.3.261","article-title":"Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma","volume":"134","author":"Hochwald","year":"1999","journal-title":"Arch Surg"},{"key":"10.1016\/j.critrevonc.2008.09.008_bib79","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1600-0455.2003.00049.x","article-title":"Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction. Complications, follow-up and reintervention in 154 patients","volume":"44","author":"Inal","year":"2003","journal-title":"Acta Radiol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808002205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808002205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T22:51:31Z","timestamp":1632091891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842808002205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1040842808002205"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2008.09.008","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}